CellaVision Financial Statements From 2010 to 2024
| CEVI Stock | SEK 214.50 3.00 1.42% |
Check CellaVision financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CellaVision's main balance sheet or income statement drivers, such as , as well as many indicators such as . CellaVision financial statements analysis is a perfect complement when working with CellaVision Valuation or Volatility modules.
CellaVision |
CellaVision AB Company Operating Margin Analysis
CellaVision's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CellaVision Operating Margin | 0.25 % |
Most of CellaVision's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CellaVision AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, CellaVision AB has an Operating Margin of 0.2476%. This is 100.71% lower than that of the Health Care Equipment & Supplies sector and 100.39% lower than that of the Health Care industry. The operating margin for all Sweden stocks is 104.49% lower than that of the firm.
CellaVision AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CellaVision's current stock value. Our valuation model uses many indicators to compare CellaVision value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CellaVision competition to find correlations between indicators driving CellaVision's intrinsic value. More Info.CellaVision AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CellaVision AB is roughly 1.73 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CellaVision's earnings, one of the primary drivers of an investment's value.About CellaVision Financial Statements
CellaVision shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although CellaVision investors may analyze each financial statement separately, they are all interrelated. The changes in CellaVision's assets and liabilities, for example, are also reflected in the revenues and expenses on on CellaVision's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden and internationally. CellaVision AB was founded in 1994 and is headquartered in Lund, Sweden. CellaVision operates under High Precision And Instrumentation Products classification in Sweden and is traded on Stockholm Stock Exchange. It employs 129 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CellaVision Stock Analysis
When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.